The stock of Core Scientific Inc (CORZ) has seen a 6.64% increase in the past week, with a 24.10% gain in the past month, and a -25.80% decrease in the past quarter. The volatility ratio for the week is 6.63%, and the volatility levels for the past 30 days are at 6.98% for CORZ. The simple moving average for the past 20 days is 18.12% for CORZ’s stock, with a -20.39% simple moving average for the past 200 days.
Is It Worth Investing in Core Scientific Inc (NASDAQ: CORZ) Right Now?
The 36-month beta value for CORZ is at 6.69. Analysts have varying views on the stock, with 11 analysts rating it as a “buy,” 4 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for CORZ is 258.28M, and currently, shorts hold a 18.44% of that float. The average trading volume for CORZ on May 12, 2025 was 16.58M shares.
CORZ) stock’s latest price update
The stock of Core Scientific Inc (NASDAQ: CORZ) has decreased by -1.38 when compared to last closing price of 9.45. Despite this, the company has experienced a 6.64% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-07 that Core Scientific, Inc. (NASDAQ:CORZ ) Q1 2025 Results Conference Call May 7, 2025 4:30 PM ET Company Participants Jon Charbonneau – Vice President, Investor Relations Adam Sullivan – CEO, President & Director Matt Brown – Chief Operating Officer Jim Nygaard – Chief Financial Officer Conference Call Participants Joe Flynn – Compass Point Research Brett Knoblauch – Cantor Fitzgerald Darren Aftahi – Roth MKM Nick Giles – B Riley John Todaro – Needham & Company Kevin Dede – H.C. Wainwright Paul Golding – Macquarie Capital Bill Papanastasiou – Keefe, Bruyette, & Woods Operator Good day, ladies and gentlemen, and welcome to Core Scientific First Quarter Fiscal Year 2025 Earnings Conference Call.
Analysts’ Opinion of CORZ
Many brokerage firms have already submitted their reports for CORZ stocks, with Keefe Bruyette repeating the rating for CORZ by listing it as a “Outperform.” The predicted price for CORZ in the upcoming period, according to Keefe Bruyette is $22 based on the research report published on January 27, 2025 of the current year 2025.
Craig Hallum, on the other hand, stated in their research note that they expect to see CORZ reach a price target of $24. The rating they have provided for CORZ stocks is “Buy” according to the report published on January 21st, 2025.
ROTH MKM gave a rating of “Buy” to CORZ, setting the target price at $25.50 in the report published on November 15th of the previous year.
CORZ Trading at 14.68% from the 50-Day Moving Average
After a stumble in the market that brought CORZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.97% of loss for the given period.
Volatility was left at 6.98%, however, over the last 30 days, the volatility rate increased by 6.63%, as shares surge +36.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.98% lower at present.
During the last 5 trading sessions, CORZ rose by +6.64%, which changed the moving average for the period of 200-days by -14.65% in comparison to the 20-day moving average, which settled at $7.89. In addition, Core Scientific Inc saw -33.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CORZ starting from Sullivan Adam Taylor, who sale 22,629 shares at the price of $7.52 back on Apr 01 ’25. After this action, Sullivan Adam Taylor now owns 3,736,164 shares of Core Scientific Inc, valued at $170,213 using the latest closing price.
DUCHENE TODD M, the of Core Scientific Inc, sale 7,921 shares at $7.52 during a trade that took place back on Apr 01 ’25, which means that DUCHENE TODD M is holding 2,015,502 shares at $59,581 based on the most recent closing price.
Stock Fundamentals for CORZ
Current profitability levels for the company are sitting at:
- -0.03 for the present operating margin
- 0.24 for the gross margin
The net margin for Core Scientific Inc stands at -2.58. The total capital return value is set at -0.01.
Based on Core Scientific Inc (CORZ), the company’s capital structure generated 3.16 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at -1.46. The interest coverage ratio of the stock is -0.58.
Currently, EBITDA for the company is -1.16 billion with net debt to EBITDA at -0.31. When we switch over and look at the enterprise to sales, we see a ratio of 6.15. The receivables turnover for the company is 265.28for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.26.
Conclusion
In conclusion, Core Scientific Inc (CORZ) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
